Clinical Trials Logo

Panic Disorder clinical trials

View clinical trials related to Panic Disorder.

Filter by:

NCT ID: NCT01346228 Not yet recruiting - Anxiety Disorders Clinical Trials

Using Smart Phone Technology To Rural Veterans

Start date: April 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to see if a new Smart Phone application can help Veterans manage their panic symptoms after completing a two-day treatment for panic attacks.

NCT ID: NCT01323556 Recruiting - Panic Disorder Clinical Trials

Mechanisms of Panic Disorders Treatment

Start date: March 2010
Phase: Phase 2/Phase 3
Study type: Interventional

Investigation of mechanisms of exposure based learning by 1. Investigating the effects of fear augmentation by interoceptive exposure during in vivo exposure 2. Disentangling the effects of interoceptive exposure exercises in panic disorder

NCT ID: NCT01201967 Completed - Depression Clinical Trials

A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients

MOSAIC
Start date: September 2010
Phase: Phase 4
Study type: Interventional

For this trial, the investigators propose a prospective trial of a collaborative care program to identify and treat depression, generalized anxiety disorder, and panic disorder among patients admitted to the hospital for an acute cardiac illness (acute coronary syndrome, congestive heart failure, or arrhythmia). Such assessment and treatment for depression/generalized anxiety disorder/panic disorder will begin in the hospital, and ongoing management will continue for six months following discharge. The investigators hypothesize that this model will lead to increased treatment rates, improved mood, reduced anxiety, and improved medical outcomes in this vulnerable population. If this model is effective, it could be implemented clinically to provide better and more complete care to patients hospitalized with acute cardiac illness, for whom depression and anxiety may be a risk factor for complications and death. This will be a two-arm, single-blind randomized controlled trial, with one-half of patients randomized to collaborative care and one-half randomized to the control condition (usual care). Psychiatric treatment in the intervention arm will be provided in concert with patients' primary care physicians—with primary care physicians prescribing all medications—within a framework supervised by a psychiatrist. The investigators will enroll patients who have any (or all) of the three included psychiatric diagnoses to improve the utility of the intervention. The investigators have chosen to enroll patients with several different cardiac diagnoses. This will allow the researchers to include patients with heterogeneous diagnoses and illness severity to determine if our intervention is effective in a broad population of patients with heart disease. The investigators will study an intervention targeting depression, generalized anxiety disorder, and panic disorder: all three disorders are disabling and associated with adverse cardiovascular outcomes, treatments for the conditions are highly similar, the investigators can treat patients who have more than one disorder, and a prior outpatient program successfully simultaneously addressed more than one mental health condition. The project will involve: (1) screening patients for depression, generalized anxiety disorder, and panic disorder as part of usual clinical care, (2) evaluation of positive-screen patients by a study social work care manager, (3) a multicomponent in-hospital intervention (for collaborative care patients) that involves patient education, specialist-provided treatment recommendations, and a goal of in-hospital treatment initiation, and (4), after discharge, continued phone-based evaluation and care coordination with primary care physicians to provide stepwise treatment in the collaborative care arm. The intervention has been designed to be low-cost, low-burden, and easily generalizable to other settings.

NCT ID: NCT01172652 Completed - Bipolar Disorder Clinical Trials

Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)

Pfizer Anxiety
Start date: April 2010
Phase: Phase 4
Study type: Interventional

The specific aim of this study is to evaluate the efficacy, tolerability, and safety of ziprasidone monotherapy in comparison to placebo in the treatment of ambulatory bipolar disorder with co-morbid lifetime panic disorder or generalized anxiety disorder and current at least moderately severe anxiety.

NCT ID: NCT01076777 Completed - Panic Disorder Clinical Trials

Physical Exercise Versus Cognitive-behavioral Therapy (CBT) for Panic Disorders: A Randomised Controlled Trial

Start date: May 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare manualised physical exercise conducted in groups to manualised cognitive-behavioral therapy conducted in groups as treatment for panic disorder with or without agoraphobia.

NCT ID: NCT01075672 Active, not recruiting - Depression Clinical Trials

Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals

Start date: January 2010
Phase: N/A
Study type: Interventional

To examine the effectiveness and clinical care outcomes of cognitive-behavioral therapy interventions at Massachusetts General Hospital (MGH).

NCT ID: NCT01033136 Completed - PTSD Clinical Trials

Exposure Therapy For Veterans With PTSD And Panic Attacks

Start date: January 1, 2013
Phase: N/A
Study type: Interventional

To evaluate the feasibility, acceptability and effectiveness of Multiple Channel Exposure Therapy-Veterans (MCET-V) as a treatment for returning service members with comorbid PTSD and panic disorder (PD). This study will examine the effectiveness of MCET-V by comparing it to Cognitive Processing Therapy, a standard PTSD treatment.

NCT ID: NCT01025908 Completed - Panic Disorder Clinical Trials

Cognitive Behavior Psychotherapy in Panic Disorder

Start date: May 2006
Phase: N/A
Study type: Interventional

The objective of this study in cognitive-behavioural therapy (CBT) was to demonstrate the preparation of the patient with panic disorder for agoraphobic exposures. The focus of the work consisted of interoceptive exposures, in vivo, of body sensations themselves, to feared places and situations. The sample consisted of 50 individuals. Group 1 undertook 10 weekly, individual sessions of CBT of one hour duration. Group 2, control, was just follow-up with supportive therapy. The procedures used for the exposures, especially for induction symptom exercises, were considered essential in the preparation of patients with panic disorder, to be able to face up to panic attacks and subsequent agoraphobic situations.

NCT ID: NCT01008371 Withdrawn - Obesity Clinical Trials

Investigation of Neuro-hormonal Mechanisms of Hunger, Fullness and Obesity.

Start date: October 2009
Phase: N/A
Study type: Observational

The purpose of this study is to determine abnormal neuro-hormonal mechanisms that may impair the ability to feel full and which therefore, may lead to obesity.

NCT ID: NCT00947570 Completed - Anxiety Disorders Clinical Trials

Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study)

Start date: October 2007
Phase: N/A
Study type: Interventional

This study will examine the effects of cognitive behavioral therapy on brain function in people with anxiety disorders.